"10.1371_journal.pone.0090226","plos one","2014-03-05T00:00:00Z","Michael Phillips; J David Beatty; Renee N Cataneo; Jan Huston; Peter D Kaplan; Roy I Lalisang; Philippe Lambin; Marc B I Lobbes; Mayur Mundada; Nadine Pappas; Urvish Patel","Breath Research Laboratory, Menssana Research Inc., Newark, New Jersey, United States of America; Department of Medicine, New York Medical College, Valhalla, New York, United States of America; Swedish Cancer Institute, Seattle, Washington, United States of America; HackensackUMC Mountainside, Montclair, New Jersey, United States of America; Division of Medical Oncology, Department of Internal Medicine, GROW School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Radiotherapy (MAASTRO), GROW School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Department of Radiology, GROW School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands; Saint Michaels Medical Center, Newark, New Jersey, United States of America","Conceived and designed the experiments: MP. Performed the experiments: JDB JH RIL PL MBIL NP. Contributed reagents/materials/analysis tools: RNC PDK MM UP. Wrote the paper: MP. Reviewed and revised the manuscript: MP JDB RNC JH PDK RIL PL.","Michael Phillips is President and CEO of Menssana Research, Inc., which develops and patents breath tests for biomarkers of diseases. Renee N Cataneo, Peter D Kaplan, Mayur Mundada and Urvish Patel are current or former employees of Menssana Research, Inc. Schmitt & Associates, Newark, NJ, analyzed the data. This does not alter our adherence to PLOS ONE policies on sharing data and materials.","2014","03","Michael Phillips","MP",11,TRUE,1,6,NA,1,TRUE,FALSE,FALSE,0,NA,FALSE
